biomedicina slovenica

pr=Bogaerts : 6

  1. Steenbeek Miranda P.; Bommel Majke H. D. van; Bulten Johan; Bogaerts Joep; Cun Han T.; Lu Karen H.; Beekhuizen Heleen J van; Minig Lucas; Gaarenstroom Katja N.; Krajc Mateja
    Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy
    2022 ►
  2. Cardoso Fatima; Bogaerts Jan; Slaets L.; Viale Giuseppe; Delaloge S.; Pierga J.-Y.; Brain E.; Causeret S.; DeLorenzi M.; Matos Erika
    70-gene signature as an aid to treatment decisions in early-stage breast cancer
    2016 ►
  3. Bonnefoi Herve; Piccart Martine; Bogaerts Jan; Čufer Tanja
    TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
    2011 ►
  4. Paridaens Robert J; Dirix LucY; Beex Louk V; Nooij Marianne; Cameron David A; Čufer Tanja; Piccart Martine J; Bogaerts Jan; Therasse Patrick
    Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
    2008 ►
  5. Pajk Bojana; Čufer Tanja; Canney Peter; Ellis Paul; Cameron David; Blot Emmanuel; Vermorken Jan; Coleman Robert; Marreaud Sandrine; Bogaerts Jan
    Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from EORTC 10001 randomized phase II trial
    2008 ►
  6. Rammeloo J; Bogaerts A
    EuroGard 3. Abstracts of the 3rd European botanic gardens congress; 2003 Jul 21-26; Meise and BEDUCO 2. Abstracts of the 2nd European botanic gardens education congress; 2003 Jul 20-25; Meise
    2003 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics